Premium
The challenges of establishing adequate capacity for SARS ‐ C o V ‐2 testing
Author(s) -
Smith David W
Publication year - 2020
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja2.50610
Subject(s) - pandemic , contact tracing , outbreak , covid-19 , coronavirus , isolation (microbiology) , virology , medicine , diagnostic test , quarantine , biology , disease , veterinary medicine , infectious disease (medical specialty) , bioinformatics , pathology
1 University of Western Australia, Perth, WA. 2 PathWest Laboratory Medicine WA, Perth, WA. david.smith@health.wa.gov.au ▪ doi: 10.5694/mja2.50610 ▪ See Research (Caly). Severe acute respiratory syndrome coronavirus 2 (SARSCoV2), the virus that causes coronavirus disease 2019 (COVID19), has spread rapidly throughout the world from its origins in China in late 2019; the COVID19 outbreak was declared a pandemic by the World Health Organization on 11 March 2020.1 It is the seventh coronavirus known to have crossed from animals to humans, and may become the fifth to persist as an endemic human coronavirus.2
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom